Design Therapeutics
DSGN
#7040
Rank
A$0.99 B
Marketcap
A$15.49
Share price
-1.04%
Change (1 day)
36.18%
Change (1 year)

Earnings for Design Therapeutics (DSGN)

Earnings in 2026 (TTM): -A$0.12 Billion

According to Design Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.12 Billion a decrease over its 2024 earnings that were of -A$92.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Design Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.12 Billion1.81%
2025 -A$0.12 Billion27.39%
2024 -A$92.29 Million-20.22%
2023 -A$0.12 Billion15.68%
2022 -A$100 Million88.64%
2021 -A$53.01 Million330.14%
2020 -A$12.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 89.76%๐Ÿ‡บ๐Ÿ‡ธ USA